Vasopressin in pediatric shock and cardiac arrest

Karen Choong1, Niranjan Kissoon

  • 1Pediatric Critical Care and Neonatology, McMaster Children's Hospital, Hamilton, Ontario, Canada. choongk@mcmaster.ca

Insights

Vasopressin shows promise for treating pediatric shock and cardiac arrest, with observational studies indicating improved blood pressure. However, use in children requires caution due to limited evidence, pending further trials.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Cardiovascular physiology

Background:

  • Vasopressin is used in adults for vasodilatory shock and cardiac arrest.
  • Limited data exists on vasopressin's efficacy and safety in pediatric populations.
  • Current pediatric dosing is extrapolated from adult studies.

Purpose of the Study:

  • To review the physiology of vasopressin.
  • To synthesize published literature on vasopressin's role in pediatric shock.
  • To assess the current evidence for vasopressin use in children.

Main Methods:

  • Comprehensive literature search of MEDLINE, EMBASE, and Cochrane Library (1966-2007).
  • Inclusion of studies using terms: vasopressin, terlipressin, and shock in pediatrics.
  • Review of reference lists and ongoing trial registries.

Main Results:

  • Observational studies suggest beneficial effects of low-dose vasopressin in pediatric shock.
  • Reported improvements include enhanced blood pressure and reduced catecholamine dependence.
  • Evidence for vasopressin in pediatric vasodilatory shock and cardiac arrest is currently limited.

Conclusions:

  • Vasopressin presents a potential therapeutic option for pediatric shock and cardiac arrest.
  • Cautious administration is recommended due to limited pediatric experience.
  • Results from a forthcoming randomized controlled trial in children are anticipated.
Abstract

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...